Melanoma Survival Rate and Vitiligo

August 1, 2003
Walter Alexander

Chicago - Among patients receiving a novel immune-based maintenance biotherapy regimen (mBT) for metastatic melanoma, those who developed vitiligo had longer median survival.

Related Content:

News